Frances L Johnson
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$1.8MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 21, 2020 | NIH | SBIR Phase II Phase 1 cross over biodistribution study of [203Pb]VMT01 for single photon emission computed tomography (SPECT) and [68Ga]VMT02 for positron emission tomography (PET) imaging of stage 4 melanoma | $1.0M | VIEWPOINT MOLECULAR TARGETING, INC. |
| May 13, 2019 | NIH | SBIR Phase I Receptor-targeted radionuclide therapy combined with immunotherapies to improve metastatic melanoma tumor response. | $300K | VIEWPOINT MOLECULAR TARGETING, INC. |
| Jan 16, 2017 | NIH | SBIR Phase I Production of Image-Guided Metastatic Melanoma Therapy Radiopharmaceuticals | $50K | VIEWPOINT MOLECULAR TARGETING, INC. |
| Dec 23, 2015 | NIH | SBIR Phase I Production of Image-Guided Metastatic Melanoma Therapy Radiopharmaceuticals | $299K | VIEWPOINT MOLECULAR TARGETING, INC. |
| Apr 9, 2015 | NIH | SBIR Phase I Image guided therapy for metastatic melanoma | $150K | VIEWPOINT MOLECULAR TARGETING, INC. |
Peer ranks
Federal funding#1,161
Awards as PI#417
Patents#273
Companies
- VIEWPOINT MOLECULAR TARGETING, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.